Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raja

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Cancer Biology & Therapy|September 5, 2008
A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cellsSrikumar M Raja, Robert J Clubb, Mitra Bhattacharyya, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin BJ T Guptill, S M Raja, V C Juel, et al.
The Journal of Biological Chemistry|March 25, 2005
A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cellsSrikumar M Raja, Sunil S Metkar, Stefan Höning, et al.
Bioarchitecture|August 26, 2011
ESCRT proteins: Double-edged regulators of cellular signalingChun Tu, Gulzar Ahmad, Bhopal Mohapatra, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|January 10, 2022
Effect of <i>Yoganidra</i> on Blood Pressure, Hs-CRP, and Lipid Profile of Hypertensive Subjects: A Pilot StudyJ P Devraj, B Santosh Kumar, M Raja Sriswan, et al.
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
The Journal of Biological Chemistry|September 17, 2014
A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cellsTameka A Bailey, Haitao Luan, Eric Tom, et al.
Frontiers in Neurology|February 28, 2017
B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease SeverityJohn S Yi, Melissa A Russo, Janice M Massey, et al.
Biotechnology Reports (Amsterdam, Netherlands)|April 24, 2026
From screening to sequencing: Investigating the monoethylene glycol (MEG) biodegradation by <i>Stutzerimonas stutzeri</i> EX72 strain to optimize Oil and Gas industrial produced water treatmentMohammad Yousaf Ashfaq, Gaurav Thareja, Farhan A Khan, et al.
Developmental Neuroscience|June 10, 2025
Developmental Progression of Inhibitory Control and Flexible Problem-solving Among Infants with Histories of Preterm BirthSrishti Jayakumar, Ezequiel Ramos, Kathryn A Carson, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Cancer Biology & Therapy|September 5, 2008
A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cellsSrikumar M Raja, Robert J Clubb, Mitra Bhattacharyya, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin BJ T Guptill, S M Raja, V C Juel, et al.
The Journal of Biological Chemistry|March 25, 2005
A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cellsSrikumar M Raja, Sunil S Metkar, Stefan Höning, et al.
Bioarchitecture|August 26, 2011
ESCRT proteins: Double-edged regulators of cellular signalingChun Tu, Gulzar Ahmad, Bhopal Mohapatra, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|January 10, 2022
Effect of <i>Yoganidra</i> on Blood Pressure, Hs-CRP, and Lipid Profile of Hypertensive Subjects: A Pilot StudyJ P Devraj, B Santosh Kumar, M Raja Sriswan, et al.
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
The Journal of Biological Chemistry|September 17, 2014
A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cellsTameka A Bailey, Haitao Luan, Eric Tom, et al.
Frontiers in Neurology|February 28, 2017
B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease SeverityJohn S Yi, Melissa A Russo, Janice M Massey, et al.
Biotechnology Reports (Amsterdam, Netherlands)|April 24, 2026
From screening to sequencing: Investigating the monoethylene glycol (MEG) biodegradation by <i>Stutzerimonas stutzeri</i> EX72 strain to optimize Oil and Gas industrial produced water treatmentMohammad Yousaf Ashfaq, Gaurav Thareja, Farhan A Khan, et al.
Developmental Neuroscience|June 10, 2025
Developmental Progression of Inhibitory Control and Flexible Problem-solving Among Infants with Histories of Preterm BirthSrishti Jayakumar, Ezequiel Ramos, Kathryn A Carson, et al.
Pageof 21